Roswell Park Cancer Institute
Clinical trials sponsored by Roswell Park Cancer Institute, explained in plain language.
-
Cancer Patients' COVID-19 trial halted after just 4 participants
Disease control TerminatedThis early-stage study tested two drugs, rintatolimod and interferon alpha-2b, in cancer patients with COVID-19. The goal was to see if the combination could boost the immune system to fight the virus. Only 4 people took part before the study was stopped early. The main focus was…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:31 UTC
-
Experimental combo for tough melanoma shows early promise but study halted
Disease control TerminatedThis study tested a new treatment for people with advanced melanoma that stopped responding to standard immunotherapy. The approach combined a special type of immune cell (dendritic cell therapy) with three drugs to boost the immune system and fight tumors. Only one person enroll…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
Light and immune combo shows promise in tough lung cancers
Disease control TerminatedThis early-phase study tested a treatment that uses a light-activated drug (photodynamic therapy) plus immunotherapy to fight non-small cell lung cancer with pleural spread or malignant pleural mesothelioma. Only 5 people took part before the study ended early. The main goal was …
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
New combo aims to outsmart drug resistance in advanced prostate cancer
Disease control TerminatedThis early-phase trial tested a combination of two drugs—decitabine/cedazuridine and enzalutamide—in 8 men with metastatic castration-resistant prostate cancer that had stopped responding to standard treatment. The goal was to find a safe dose and see if the combination could rev…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Lung cancer combo therapy study halted early
Knowledge-focused TerminatedThis study looked at giving a precise, high-dose radiation treatment (SBRT) before surgery for people with stage I to IIIA non-small cell lung cancer. The goal was to see if this approach was safe and how it affected survival. The study was stopped early, and only 20 people took …
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:30 UTC
-
Vapers put to the test: can you identify that E-Liquid flavor?
Knowledge-focused TerminatedThis study looked at how well daily vapers and experts can identify and detect flavors and odors in e-liquids. Participants rated the intensity of different flavors and combinations. The goal was to understand how people perceive these flavors, which may help inform future resear…
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Brain scans and VR aim to decode cancer pain
Knowledge-focused TerminatedThis study explored whether a special brain scan (fNIRS) can measure pain in cancer patients and survivors. Researchers also tested if virtual reality (VR) can help reduce pain by distracting the brain. The goal was to create better, non-drug ways to assess and manage cancer pain…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Vape flavors alter puffing habits, study finds
Knowledge-focused TerminatedThis study looked at how different vape flavors and liquid ingredients affect the way people puff on e-cigarettes. Researchers measured puff counts, duration, and volume in 21 daily vapers. The goal was to understand how these factors influence vaping behavior and potential healt…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC